Ayr Wellness (AYR.A) Stock Overview
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
AYR.A Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ayr Wellness Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.15 |
| 52 Week High | CA$3.60 |
| 52 Week Low | CA$0.12 |
| Beta | 1.51 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -93.60% |
| 3 Year Change | -97.21% |
| 5 Year Change | -99.11% |
| Change since IPO | -98.95% |
Recent News & Updates
Recent updates
New Indoor Cultivation Facilities In Ocala Will Improve Operations
Investment in core brands and new cultivation facilities aims to enhance product quality and drive revenue growth.Ayr Wellness Inc. (CSE:AYR.A) Not Doing Enough For Some Investors As Its Shares Slump 30%
Jan 01
Ayr Wellness Inc.'s (CSE:AYR.A) 29% Share Price Surge Not Quite Adding Up
Nov 03Ayr Wellness (CSE:AYR.A) Has Debt But No Earnings; Should You Worry?
Oct 23Ayr Wellness Inc. (CSE:AYR.A) Not Doing Enough For Some Investors As Its Shares Slump 28%
Aug 28Does Ayr Wellness (CSE:AYR.A) Have A Healthy Balance Sheet?
Jul 17Ayr Wellness Inc.'s (CSE:AYR.A) Shares Not Telling The Full Story
May 24Is Ayr Wellness Inc. (CSE:AYR.A) Worth CA$2.1 Based On Its Intrinsic Value?
Dec 22Is Ayr Wellness (CSE:AYR.A) Using Debt Sensibly?
Oct 06Ayr Wellness Inc.'s (CSE:AYR.A) Share Price Boosted 33% But Its Business Prospects Need A Lift Too
Sep 01Ayr Wellness Inc. (CSE:AYR.A) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Sep 01Is There An Opportunity With Ayr Wellness Inc.'s (CSE:AYR.A) 33% Undervaluation?
Jul 11Shareholder Returns
| AYR.A | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -21.1% | -1.7% |
| 1Y | -93.6% | -24.3% | 18.6% |
Return vs Industry: AYR.A underperformed the Canadian Pharmaceuticals industry which returned -5.6% over the past year.
Return vs Market: AYR.A underperformed the Canadian Market which returned 19.6% over the past year.
Price Volatility
| AYR.A volatility | |
|---|---|
| AYR.A Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 11.6% |
| Market Average Movement | 10.0% |
| 10% most volatile stocks in CA Market | 19.5% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: AYR.A's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine AYR.A's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 2,440 | Scott Davido | www.ayrwellness.com |
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company engages in the possession, manufacture, use, sale, or distribution of cannabis and/or holding of licenses in the adult-use and/or medicinal cannabis marketplace. Its portfolio includes consumer-packaged goods under the kynd, HAZE, and Later Days brand names, as well as legacy and local brands.
Ayr Wellness Inc. Fundamentals Summary
| AYR.A fundamental statistics | |
|---|---|
| Market cap | CA$18.10m |
| Earnings (TTM) | -CA$494.07m |
| Revenue (TTM) | CA$637.52m |
Is AYR.A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AYR.A income statement (TTM) | |
|---|---|
| Revenue | US$463.63m |
| Cost of Revenue | US$286.95m |
| Gross Profit | US$176.68m |
| Other Expenses | US$535.99m |
| Earnings | -US$359.31m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.08 |
| Gross Margin | 38.11% |
| Net Profit Margin | -77.50% |
| Debt/Equity Ratio | 112.5% |
How did AYR.A perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/02 20:24 |
| End of Day Share Price | 2025/06/05 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ayr Wellness Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matt Bottomley | Canaccord Genuity |
| Owen Bennett | Jefferies LLC |
| Gregory Gibas | Northland Capital Markets |